+86-28-82633987sales@biopurify.com
Batch Search
Alternate Text
Home > Product Category > Compound Types > Iridoids

Shanzhiside methylester

CAS No.:64421-28-9

Shanzhiside methylester
Catalogue No.: BP1300
Formula: C17H26O11
Mol Weight: 406.384
Botanical Source: Lamiophlomis herba
Contacts
+86-28-82633860  +86-18080483897
 
Email: sales@biopurify.com biopurify@gmail.com

Shanzhiside methylester

CAS No.:64421-28-9

Shanzhiside methylester
Catalogue No.: BP1300
Formula: C17H26O11
Mol Weight: 406.384
Botanical Source: Lamiophlomis herba
Contacts
+86-28-82633860  +86-18080483897
 
Email: sales@biopurify.com biopurify@gmail.com
Over 15 years of industry experience in phytochemicals from R&D(reference substances) to Industrialization, please feel free to contact us!


Product name: Shanzhiside methylester
Synonym name:
Catalogue No.: BP1300
Cas No.: 64421-28-9
Formula: C17H26O11
Mol Weight: 406.384
Botanical Source: Mussaenda parviflora and Salvia digitaloides
Physical Description: Powder
Type of Compound: Iridoids

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams, up to kilograms
Inquire for bulk scale.

Descriptions:
Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata , reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling; stimulation of the endogenous β-endorphin expression may be a novel and effective strategy for the discovery and development of analgesics for the long-term treatment of chronic pain. [1]

References:
[1] Fan H, Li T F, Gong N, et al. Neuropharmacol, 2015, 101:98-109.
[2] Xi H E, Mao X, Fan P C, et al. Chinese J Exp Trad Med Formulae. 2010, 16(07):50-2


MORE>>Our products had been cited by the following academic papers, which still growing...
MORE>>Literature Citation